6 Matching Annotations
  1. Apr 2024
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
    1
    1. scibot 24 Apr 2024
      RRID:CVCL_E218

      DOI: 10.1038/s41467-024-47771-x

      Resource: (RRID:CVCL_E218)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_E218

      What is this?
      RRID:CVCL_E218
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11039739/
  3. Jul 2023
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
    1
    1. scibot 19 Jul 2023
      RRID:CVCL_E218

      DOI: 10.1158/0008-5472.CAN-21-4309

      Resource: (RRID:CVCL_E218)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_E218

      What is this?
      RRID:CVCL_E218
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9938728/
  5. Jun 2022
  6. www.sciencedirect.com www.sciencedirect.com
    Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma
    1
    1. scibot 22 Jun 2022
      RRID:CVCL_e218

      DOI: 10.1016/j.celrep.2022.111000

      Resource: (RRID:CVCL_E218)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_E218

      What is this?
      RRID:CVCL_E218
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124722007896
  7. Dec 2021
  8. www.sciencedirect.com www.sciencedirect.com
    GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
    1
    1. scibot 31 Dec 2021
      RRID:CVCL_E218

      DOI: 10.1016/j.ccell.2021.12.005

      Resource: (RRID:CVCL_E218)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_E218

      What is this?
      RRID:CVCL_E218
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610821006589
  9. Jul 2021
  10. www.sciencedirect.com www.sciencedirect.com
    A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope
    1
    1. scibot 22 Jul 2021
      CVCL_E218

      DOI: 10.1016/j.xcrm.2021.100344

      Resource: (RRID:CVCL_E218)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_E218

      What is this?
      RRID:CVCL_E218
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121001932
  11. Nov 2017
  12. www.sciencedirect.com www.sciencedirect.com
    Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
    1
    1. scibot 08 Nov 2017
      CVCL_E218

      Curator: @Jmenke

      Resource used:

      RRID:CVCL_E218

      SciCrunch record: RRID:CVCL_E218

      Alternate resolvers: SciCrunch xml N2T identifiers.org

      What is this?

      RRID:CVCL_E218 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S153561081730346X